OTCBB:GTBP

Gt Biopharma Stock Insider Trading

etoro logo Buy GTBP
*Your capital is at risk
$0.294
-0.0143 (-4.65%)
At Close: Jul 31, 2026

GT Biopharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 10.86M and sold 660K GTBP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 10.86M shares
Sell 660K shares
94% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Feb 25, 2021
Buy
Common Stock
C-Conversion
Breen Michael Martin
Insider
Other 9 859
Value: $33.5K
Feb 16, 2021
Buy
Common Stock
A-Award
Berk Gregory
Insider
Other 278 058
Value: $0
Feb 16, 2021
Buy
Option to purchase Common Stock
A-Award
Berk Gregory
Insider
Other 50 000
Value: $316.5K
Feb 16, 2021
Buy
Option to purchase Common Stock
A-Award
Shrotriya Rajesh C Md
Insider
Other 50 000
Value: $316.5K
Feb 16, 2021
Buy
Option to purchase Common Stock
A-Award
Shrotriya Rajesh C Md
Insider
Other 50 000
Value: $316.5K
Feb 16, 2021
Buy
Option to purchase Common Stock
A-Award
Berk Gregory
Insider
Other 50 000
Value: $316.5K
Feb 16, 2021
Buy
Common Stock
A-Award
Berk Gregory
Insider
Other 278 058
Value: $0
Feb 16, 2021
Buy
Common Stock
A-Award
Breen Michael Martin
Insider
Other 278 058
Value: $0
Feb 16, 2021
Buy
Option to purchase Common Stock
A-Award
Breen Michael Martin
Insider
Other 50 000
Value: $316.5K
Feb 16, 2021
Buy
Option to purchase Common Stock
A-Award
Breen Michael Martin
Insider
Other 50 000
Value: $316.5K
Feb 16, 2021
Buy
Common Stock
A-Award
Breen Michael Martin
Insider
Other 278 058
Value: $0
Feb 16, 2021
Buy
Common Stock
A-Award
Wendel Bruce
Insider
Other 347 572
Value: $0
Feb 16, 2021
Buy
Option to purchase Common Stock
A-Award
Wendel Bruce
Insider
Other 50 000
Value: $316.5K
Feb 16, 2021
Buy
Option to purchase Common Stock
A-Award
Wendel Bruce
Insider
Other 50 000
Value: $316.5K
Feb 16, 2021
Buy
Common Stock
A-Award
Wendel Bruce
Insider
Other 347 572
Value: $0
Jan 13, 2021
Buy
Common Stock
J-Other
Shrotriya Rajesh C Md
Insider
Other 0
Value: $0
Jan 13, 2021
Buy
Common Stock
J-Other
Shrotriya Rajesh C Md
Insider
Other 0
Value: $0
Dec 22, 2020
Buy
Common Stock
P-Purchase
Wendel Bruce
Insider
Other 1 374
Value: $12.2K
Dec 22, 2020
Buy
Common Stock
P-Purchase
Wendel Bruce
Insider
Other 441
Value: $4K
Nov 16, 2020
Buy
Common Stock
P-Purchase
Wendel Bruce
Insider
Other 3 268
Value: $10.3K
Nov 11, 2020
Buy
Common Stock
J-Other
Berk Gregory
Insider
Other 0
Value: $0
Nov 11, 2020
Buy
Common Stock
J-Other
Berk Gregory
Insider
Other 0
Value: $0
Nov 11, 2020
Buy
Common Stock
J-Other
Wendel Bruce
Insider
Other 0
Value: $0
Jun 23, 2020
Buy
10% Senior Convertible Debenture
Breen Michael Martin
Insider
Other 0
Value: $0
Jun 23, 2020
Buy
10% Senior Convertible Debenture
Breen Michael Martin
Insider
Other 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT GT BIOPHARMA, INC.
GT Biopharma
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I/II clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE